Malik Fady Ibraham bought CYTK

June 9, 2026 · Form 4 insider transaction

Malik Fady Ibraham bought 3,500 shares of Cytokinetics, Incorporated at $7.80 per share, a transaction worth $27.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.